English ticker view
LYEL
LYELL IMMUNOPHARMA INC
This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.
Current price
$15.69
Public comments
0
13F holding rows
31
Insider trade rows
7
Public comments
0
Ranked by current return where prices are available.
13F direction
27 / 4
New or increased positions vs reduced or sold positions.
Insider activity
2 buyers
Based on SEC Form 4 market purchase and sale rows.
Latest comments
Most recent public records
SEC 13F
Institution holding changes
Nuveen Asset Management, LLC
decreased · Feb 14, 2025
+2351.6%
Filing price $0.64 · Current $15.69
JPMorgan Chase & Co.
sold out · May 13, 2026
-18.7%
Filing price $19.2902 · Current $15.69
Dimensional Fund Advisors LP
new · May 7, 2026
-21.7%
Filing price $20.0259 · Current $15.69
Mirae Asset Global Investments Co., Ltd.
new · May 4, 2026
-21.8%
Filing price $20.0596 · Current $15.69
FMR LLC / Fidelity
new · May 15, 2026
-21.8%
Filing price $20.0598 · Current $15.69
Barclays PLC
new · May 15, 2026
-21.8%
Filing price $20.0598 · Current $15.69
UBS Group AG
new · May 5, 2026
-21.8%
Filing price $20.06 · Current $15.69
Two Sigma Investments, LP
new · May 15, 2026
-21.8%
Filing price $20.06 · Current $15.69
Insider trades
SEC Form 4 summary
Market buys
2 owners
Rows
2
Estimated amount
$24,999,969.80
Average price $25.61 · Latest Mar 6, 2026